Predictive Value of CD229, CD319 and c-Maf Overexpression for Treatment Response in Multiple Myeloma Patients

Role of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients

Aberrant Expression of CD56 in Hematologic Malignancies

CD 11b and CD56 As Prognostic Markers in Acute Myeloid Leukemia

Prognostic Impact of Flow Cytometric Measurement of G Protein–Coupled Receptor 56 (GPR56) in Acute Myeloid Leukemia

Impact of CRAB Criteria on The Prognosis of Patients with Multiple Myeloma Compared to Other Prognostic Factors in The Era of Novel Agents

Clinical Significance of CD200 and CD56 in Patients with Acute Lymphoblastic Leukemia

Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt

Diagnostic and Prognostic Value of CD123 in Acute Leukemia

Prognostic Value of Transgelin-2 As A Predictor of Renal Affection in Multiple Myeloma at Benha University Hospital